DocMorris AG (ZRSEF)
95.77
0.00 (0.00%)
USD |
OTCM |
Apr 22, 16:00
DocMorris Total Assets (Quarterly): 1.032B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.032B |
| June 30, 2023 | 1.124B |
| June 30, 2023 | 1.124B |
| December 31, 2022 | 1.186B |
| June 30, 2022 | 1.199B |
| June 30, 2022 | 1.199B |
| December 31, 2021 | 1.388B |
| June 30, 2021 | 1.359B |
| June 30, 2021 | 1.359B |
| December 31, 2020 | 1.463B |
| June 30, 2020 | 1.137B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.137B |
| December 31, 2019 | 1.024B |
| June 30, 2019 | 834.79M |
| June 30, 2019 | 834.79M |
| December 31, 2018 | 737.93M |
| June 30, 2018 | 451.48M |
| June 30, 2018 | 451.48M |
| December 31, 2017 | 474.05M |
| June 30, 2017 | 271.81M |
| June 30, 2017 | 271.81M |
| December 31, 2016 | 257.01M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
834.79M
Minimum
Jun 2019
1.463B
Maximum
Dec 2020
1.160B
Average
1.137B
Median
Jun 2020
Total Assets (Quarterly) Benchmarks
| AC Immune SA | 217.65M |
| CRISPR Therapeutics AG | 2.230B |
| Addex Therapeutics Ltd | 5.526M |
| NLS Pharmaceutics Ltd | 2.270M |
| Molecular Partners AG | 236.15M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 518.95M |
| Shareholders Equity (Quarterly) | 512.57M |
| Debt to Equity Ratio | 0.7017 |
| Current Ratio | 1.629 |
| Net Debt Paydown Yield | 5.60% |